Nationwide Estimates of 30-Day Readmission in Patients With Ischemic Stroke

Author:

Vahidy Farhaan S.1,Donnelly John P.1,McCullough Louise D.1,Tyson Jon E.1,Miller Charles C.1,Boehme Amelia K.1,Savitz Sean I.1,Albright Karen C.1

Affiliation:

1. From the Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston (F.S.V., L.D.M., S.I.S.); Department of Emergency Medicine (J.P.D.) and Department of Neurology (K.C.A.), University of Alabama School of Medicine, Birmingham; Center for Clinical Research and Evidence-Based Medicine, McGovern Medical School, University of Texas Health Science Center, Houston (J.E.T., C.C.M.); and Department of Neurology, Columbia University, New York, NY (A.K.B.).

Abstract

Background and Purpose— Readmission within 30 days of hospital discharge for ischemic stroke is an important quality of care metric. We aimed to provide nationwide estimates of 30-day readmission in the United States, describe important reasons for readmission, and sought to explore factors associated with 30-day readmission, particularly the association with recanalization therapy. Methods— We conducted a weighted analysis of the 2013 Nationwide Readmission Database to represent all US hospitalizations. Adult patients with acute ischemic stroke including those who received intravenous tissue-type plasminogen activator and intra-arterial therapy were identified using International Classification of Diseases -Ninth Revision codes. Readmissions were defined as any readmission during the 30-day post-index hospitalization discharge period for the eligible patient population. Proportions and 95% confidence intervals for overall 30-day readmissions and for unplanned and potentially preventable readmissions are reported. Survey design logistic regression models were fit for determining crude and adjusted odds ratios and 95% confidence interval for association between recanalization therapy and 30-day readmission. Results— Of the 319 317 patients with acute ischemic stroke, 12.1% (95% confidence interval, 11.9–12.3) were readmitted. Of these, 89.6% were unplanned and 12.9% were potentially preventable. More than 20% of all readmissions were attributable to acute cerebrovascular disease. Readmitted patients were older and had a higher comorbidity burden. After controlling for age, sex, insurance status, and comorbidities, patients who underwent recanalization therapy had significantly lower odds of 30-day readmission (odds ratio, 0.82; 95% confidence interval, 0.77–0.89). Conclusions— Up to 12% of patients with ischemic stroke get readmitted within 30 days post-discharge period, and recanalization therapy is associated with 11% to 23% lower odds of 30-day readmission.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference14 articles.

1. Predictors of Hospital Readmission After Stroke

2. Reducing Readmissions After Stroke With a Structured Nurse Practitioner/Registered Nurse Transitional Stroke Program

3. Medicare's Readmissions-Reduction Program — A Positive Alternative

4. Readmissions reduction program, medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long term care hospital prospective payment system and proposed fiscal year 2014 rates; quality reporting requirements for specific providers; hospital conditions of participation; medicare program; fy 2014 hospice wage index and payment rate update; hospice quality reporting requirements; and updates on payment reform; proposed rules.;Centers for Medicare and Medicaid Services (CMS), HHS;Fed Regist,2013

5. Preventable Readmissions Within 30 Days of Ischemic Stroke Among Medicare Beneficiaries

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3